HPV prevention and control - The way forward

Area of Science:

• Public Health
• Infectious Diseases
• Oncology

Background:

• The COVID-19 pandemic has significantly expanded healthcare infrastructure for vaccination, testing, and public education.
• Human papillomavirus (HPV) is a common sexually transmitted infection and a leading cause of various cancers, including cervical, head and neck, and anal cancers.
• Cervical cancer elimination is a global goal, emphasizing adolescent vaccination, widespread screening, and treatment of infected women.

Purpose of the Study:

• To highlight the opportunity to leverage COVID-19 resources for HPV prevention and control.
• To summarize available tools for HPV control.
• To discuss public health threats during the ongoing COVID-19 pandemic.

Main Methods:

• This commentary synthesizes information from the COVID-19 response.
• It reviews existing strategies and tools for HPV prevention and control.
• It analyzes the potential application of pandemic-generated resources to HPV eradication efforts.

Main Results:

• The pandemic has created valuable logistical, technical, and human resources applicable to other infectious diseases.
• Existing tools for HPV prevention include vaccination and screening programs.
• Sustaining and redeploying these resources is crucial for combating HPV-induced cancers.

Conclusions:

• The infrastructure and experience gained from the COVID-19 response can be strategically applied to enhance human papillomavirus (HPV) prevention and control programs.
• Effective utilization of these resources presents a critical opportunity to advance global goals for HPV-related cancer elimination.
• Continued vigilance and resource allocation are necessary to address the ongoing public health impact of HPV infections.